GF
LJPC

Gabelli Funds’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Gabelli Funds’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$40K – 1296
2020
Q3 		$40K Hold
10,000
– – ﹤0.01% 1106
2020
Q2 		$43K Hold
10,000
– – ﹤0.01% 1045
2020
Q1 		$42K Hold
10,000
– – ﹤0.01% 1040
2019
Q4 		$39K Buy
+10,000
New +$59.1K ﹤0.01% 1080

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gabelli Funds's LJPC Position: Q4 2020 in Review

Gabelli Funds sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2020, closing a stake of 10,000 shares — an estimated $40K sold.

Gabelli Funds first reported a position in LJPC in Q4 2019 and held it in 4 quarters. The position peaked at $43K in Q2 2020. 65 funds tracked by Wall St. Rank hold LJPC as of Q4 2020.

  • Gabelli Funds reported no remaining La Jolla Pharmaceutical Company position as of Q4 2020 after selling out during the quarter.
  • Gabelli Funds sold 10,000 La Jolla Pharmaceutical Company shares in Q4 2020, an estimated $40K.
  • Gabelli Funds first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 4 quarters.
  • Gabelli Funds's La Jolla Pharmaceutical Company position peaked at $43K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2020.

Based on Gabelli Funds's 13F filing for Q4 2020, filed 5 Feb 2021.